US Patent 8993529 Antisense modulation of superoxide dismutase 1, soluble expression
Patent 8993529 was granted and assigned to Ionis Pharmaceuticals on March, 2015 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 10, 2011
Date of Patent
March 31, 2015
Patent Application Number
12987929
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8993529 Antisense modulation of superoxide dismutase 1, soluble expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
